SCHEMBL17834644

SCHEMBL17834644

CC[C@H]1CC[C@H](c2ccc(-c3cnc(-c4ccc(C[C@H](NC(=O)c5ccc(C(F)(F)F)cc5)C(=O)O)cc4)nc3)cc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIFC1 Q9BW19 5/20 0.43
▸ GPR132 Q9UNW8 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ITGB1 P05556 3/20 0.40
▸ ITGA4 P13612 3/20 0.40
▸ ITGB7 P26010 1/20 0.40
▸ CTSL P07711 1/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40
▸ PDK3 Q15120 1/20 0.40
▸ PDK4 Q16654 1/20 0.40
▸ MME P08473 1/20 0.39
▸ ACE P12821 1/20 0.39
▸ CPA1 P15085 1/20 0.39
▸ ACE2 Q9BYF1 1/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ DGAT1 O75907 2/20 0.39
▸ SOAT1 P35610 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834788 0.92 L3MBTL1 (0.40) KIFC1GPR132L3MBTL1ITGB1ITGA4
SCHEMBL17834635 0.91 ITGB1 (0.40) GPR132L3MBTL1ITGB1ITGA4MME
SCHEMBL19481404 0.91 DGAT1 (0.45) KIFC1ITGB1ITGA4ITGB7PDK1
SCHEMBL17834678 0.91 ALDH1A1 (0.38) KIFC1GPR132L3MBTL1ITGB1ITGA4
SCHEMBL17834643 0.91 ITGB1 (0.40) GPR132L3MBTL1ITGB1ITGA4MME
SCHEMBL17834669 0.91 DGAT1 (0.41) GPR132L3MBTL1ITGB1ITGA4MME
SCHEMBL17834638 0.91 ITGB1 (0.40) GPR132L3MBTL1ITGB1ITGA4MME
SCHEMBL19481403 0.90 GPR132 (0.46) KIFC1GPR132ITGB1ITGA4ITGB7
SCHEMBL17995135 0.90 CA2 (0.46) GPR132ITGB1ITGA4DGAT1
SCHEMBL17834624 0.90 L3MBTL1 (0.41) GPR132L3MBTL1ITGB1ITGA4MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230276-B1 GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-09-02 — — EP disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-08-11 — — US disclosed
WO-2016094729-A1 GLP-1 RECEPTOR MODULATORS CELGENE INTERNATIONAL II SARL (CH) 2016-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R KIFC1 4738/4885GPR132 178/4885L3MBTL1 771/4885
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R KIFC1 4738/4885GPR132 178/4885L3MBTL1 771/4885
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR KIFC1 4749/4885GPR132 228/4885L3MBTL1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback